Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis - Summary - MDSpire

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

  • By

  • Claire Palles

  • Luke Freeman-Mills

  • Edward Arbe-Barnes

  • Nathalie Feeley

  • Laura Chegwidden

  • Helen Curley

  • Sara Galavotti

  • Connor Woolley

  • Jeremy Cheadle

  • Dmitri Mouradov

  • Oliver Sieber

  • Silvia Salatino

  • Steve Thorn

  • Anshita Goel

  • Juan Fernandez-Tajes

  • Sulochana Omwenga

  • Sujata Biswas

  • Timothy Maughan

  • Simon J Leedham

  • S:CORT Consortium

  • UK Colorectal Cancer Genomics Consortium

  • CORGI Consortium

  • WGS500 Consortium

  • Viktor Hendrik Koelzer

  • Lai Mun Wang

  • Roland Arnold

  • James Edward East

  • Ian Tomlinson

  • July 1, 2026

  • 0 min

Share

Objective:

To investigate the specific genetic mechanisms of colorectal tumor development associated with germline and somatic RNF43 mutations.

Key Findings:
  • Germline RNF43 mutations can lead to colorectal cancer (CRC) but with variable phenotypes; some carriers develop CRC without multiple polyps, indicating a need for personalized risk assessment.
  • N-terminal germline mutations are associated with a six-fold increased CRC risk, while C-terminal mutations show weak or non-penetrance, highlighting the importance of mutation location in risk evaluation.
  • Somatic RNF43 mutations in microsatellite instability-positive (MSI+) sporadic CRCs act as classical tumor suppressor alleles, suggesting a complex interplay in tumorigenesis.
Interpretation:

Germline RNF43 mutations are likely more common than previously recognized, but their highly variable phenotypic expression complicates risk assessment and management in clinical settings.

Limitations:
  • The study's findings are based on a limited number of families and may not represent the broader population, potentially introducing selection bias.
  • The complexity of phenotypes associated with RNF43 mutations necessitates careful interpretation and further investigation.
Conclusion:

RNF43 should be considered a CRC predisposition gene for clinical testing, with attention to the genetic complexity involved, and further research is needed to clarify its role in CRC risk management.

Original Source(s)

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

  • by Claire Palles, Luke Freeman-Mills, Edward Arbe-Barnes, Nathalie Feeley, Laura Chegwidden, Helen Curley, Sara Galavotti, Connor Woolley, Jeremy Cheadle, Dmitri Mouradov, Oliver Sieber, Silvia Salatino, Steve Thorn, Anshita Goel, Juan Fernandez-Tajes, Sulochana Omwenga, Sujata Biswas, Timothy Maughan, Simon J Leedham, S:CORT Consortium, UK Colorectal Cancer Genomics Consortium, CORGI Consortium, WGS500 Consortium, Viktor Hendrik Koelzer, Lai Mun Wang, Roland Arnold, James Edward East, Ian Tomlinson

  • July 1, 2026

Related Content

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

Endoscopic mucosal resection versus endoscopic submucosal dissection for early colorectal cancer and precursor lesions: a retrospective study